MAP4 and cancer: Overexpression of MAP4 has been shown to sensitize cancer cells to paclitaxel by promoting microtubule stabilization, demonstrating the importance of the pre-cellular status of microtubules in determining their response to microtubule-stabilizing agents [9,10,11,12,13,14,15,16,17].